Synergistic interaction in Jensen tumor cells of two modes of exposure to inosine that potentiate the cytotoxicity of 5-fluorouracil. 1985

R E Beltz, and M J Hunter-Laszlo

The cytotoxicity resulting from a 1-h exposure of Jensen tumor (JT) cells to 5-fluorouracil (FUra), quantified in terms of growth delay, was potentiated 4.1-fold if inosine was included in the culture medium for 30 min prior to and for 1 h concurrently with drug uptake. In contrast, as reported previously, protection from FUra toxicity is induced if the cells are exposed successively to inosine for 1.5 h and to FUra for 1 h. Anabolic conversion of radiolabeled FUra to free and polymeric nucleotides was stimulated by the cytotoxicity-enhancing mode of inosine exposure but inhibited by the inosine exposure that protects against FUra. Continuous exposure of JT cells to inosine after a 1-h uptake of FUra was reported earlier to potentiate drug efficacy 5-fold. Treatment of cultures by both modes of inosine exposure that enhance FUra cytotoxicity resulted in a 15.8-fold potentiation of the latter.

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R E Beltz, and M J Hunter-Laszlo
April 1983, Biochemical and biophysical research communications,
R E Beltz, and M J Hunter-Laszlo
February 1991, Journal of chemotherapy (Florence, Italy),
R E Beltz, and M J Hunter-Laszlo
October 1997, Clinical cancer research : an official journal of the American Association for Cancer Research,
R E Beltz, and M J Hunter-Laszlo
January 1991, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!